Live Breaking News & Updates on Dalcor Pharmaceuticals

Stay updated with breaking news from Dalcor pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

dal-GenE Phase 3 Cardiovascular Precision Medicine Outcomes Trial Results Published in European Heart Journal

Trial was negatively impacted by the COVID-19 pandemic and did not meet the primary endpoint. However, the results validate the interaction between dalcetrapib treatment and AA genotype at variant rs1967309 in the ADCY9 gene.  ....

Dalcor Pharmaceuticals , Cor Pharmaceuticals , Gene Phase , European Heart Journal ,